Company Profile

Synthetic Genetics Inc (AKA: Syngen)
Profile last edited on: 12/23/10      CAGE:       UEI:

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
1985
First Award
1987
Latest Award
1988
Program Status
Inactive (Acquired)
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

3347 Industrial Court Suite A
San Diego , CA 92121
Location: Single
Congr. District: 52
County: San Diego

Public Profile

In November 2000, Synthetic Genetics Inc was acquired by SBIR firm, Epoch Biosciences, Inc. of Washington. Producer of biotech genetic engineering systems and provider of biotechnology R&D services. The company specializes in producing synthesized DNA and large scale synthesized reagents; and providing research and development services of therapeutic and diagnostic DNA. This company was capitalized by private investment.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
25-49
Revenue Range
2.5M-5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
5-9

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
1988 1 NIH $50,000
Project Title: Amphiphilic oligonnucleotide conjugates
1987 1 NIH $50,000
Project Title: New Methods for synthesis of fluorescent DNA

Key People / Management

  Ashley Birkete -- Director of Biochemsitry

Company News

There are no news available.